Now Better Searching for Health Professionals

Although a nearly infinite amount of information is nowadays accessible via the Internet, it is not easy to systematically sort out the right information. This problem is addressed by Transinsight GmbH in Dresden, a company that develops knowledge-based search technologies in close cooperation with the Technische Universität Dresden. Now, after a development period of only six months, Transinsight GmbH has created MeSHPubMed, the worldwide first knowledge-based search engine for the medical sciences to be made available on the Internet.

The search platform www.MeSHPubMed.org intelligently searches and, thus, finds the desired results much faster and much more precisely than a standard search engine can. For the first time, the technology for the intelligent search developed by Transinsight GmbH in cooperation with the TU Dresden has been used on the well-known search engine for molecular biologists www.GOPubMed.org.

"Now, medical professionals will be able to work much more efficiently, because they will be able to utilize the search engine MeSHPubMed which sorts the 16 million presently available scientific articles in such a way as is intended by the knowledge network MeSH (Medical Subject Headings), an initiative of the National Library of Medicine, USA," says Dr. Michael R. Alvers, CEO of Transinsight. The search engine allows the search time for relevant scientific information to be drastically reduced. For example, a search for the tumor suppressor protein P53 delivers about 10 million articles through conventional search engines and more than 40,000 articles in the case of standard medical search engines like www.PubMed.org. For the user, it is impossible to browse this quantity of texts. However, with www.MeSHPubMed.org, by means of interactive navigation in the knowledge tree of the MeSH, clicking the hierarchical entries "Diseases" -> "Cardiovascular Diseases" -> "Heart Diseases," means the search results can be restricted so that only six relevant articles are shown. This is a great time saver!

Prof. Dr. Michael Schroeder, co-founder of Transinsight and professor of bioinformatics at the Technische Universität Dresden, is enthused to see the practical use of technologies developed partly within European research projects such as REWERSE, Sealife and EFRE. "We are proud to have developed technologies that reach a speed and precision that currently cannot be achieved by anybody else in the world. Our ultra-fast and very precise algorithms provide an enormous customer benefit: the noticeable shortening of search times! Having already two products online is a good example of a great knowledge transfer between university and industry," says Schroeder.

This fruitful cooperation between Transinsight and the Technische Universität Dresden is based on a cooperation contract. "In Dresden, there is an atmosphere like at Stanford University, at MIT in Boston or at Cambridge University," says Alvers. On this fertile ground, Transinsight GmbH wants to open new horizons. To that end, two new search platforms are already in the beta test. Moreover, with a partner, Transinsight wants to address other areas such as the job search field, because the technology of sorted searching is global and can be used in non-biomedical areas as well.

Related news articles:

About Transinsight
Founded in November 2005, Transinsight is focused on software solutions for the life sciences providing products for knowledge based technologies. The flagship product, GoPubMed, a well established biomedical search engine, was the first knowledge based search engine for the Life Sciences on the Internet. Transinsight is headquartered in one of the leading German biotech incubators, the BioInnovationCenter Dresden BIOZ, where science and business work under one roof. Transinsight works in close collaboration with the Technische Universität Dresden. For further information, visit: http://www.transinsight.com

About REWERSE
The European Network of Excellence REWERSE is a research project on "Reasoning on the Semantic Web". REWERSE develops rule-based languages and applications to intelligently process data on the conventional and the Semantic Web. REWERSE is funded by the European Commission and Switzerland within the 6th Framework Programme, reference number 506779. The project started in March 2004 and runs for four years. REWERSE networks over 100 researches from 27 research and industry organisations in 14 European countries. For further information, visit: http://rewerse.net

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...